Health And Medicine

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about COVID-19 booster shots. Read More

MuSyC is a technique to help researchers devise new combinations of drugs. An open-source analysis tool, it holds the promise speed such discoveries around the world. Read More

A monoclonal antibody cocktail against the COVID-19 virus discovered at VUMC is the first non-vaccine modified to demonstrate the prevention of COVID-19 in a clinical trial of more than 5,000 participants. The antibody treatment could afford up to 12 months of protection from COVID-19, and preliminary laboratory findings also suggest that it can neutralize the delta variant. Read More

Three leaders of the Vanderbilt University Medical Center community are among the winners of the Nashville Business Journal’s 2021 Health Care Innovation awards. Read More

A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that prevent infection by alphaviruses, including the often-lethal Eastern equine encephalitis virus. Read More

L.J. Zwiebel and his lab show that mosquito larvae, the age group targeted for most control programs, are far more sophisticated than previously thought. Est. reading time: 2 mins. Read More

Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells. Read More

A high-fat diet disrupts the biology of the gut’s inner lining and its microbial communities — and promotes the production of a metabolite that may contribute to heart disease, according to a study published Aug. 13 in the journal Science. Read More

A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research. Read More

Paige Vega, a Ph.D. student in the Department of Cell and Developmental Biology, has been selected as the 2021 Vanderbilt Prize Student Scholar. Read More

Professor and entrepreneur finds startup success with Vanderbilt’s spirit of collaboration and innovation. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares the latest available information on when COVID-19 vaccines will be approved for children under 12. Read More

Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy. Read More

The Vanderbilt Project on Unity and American Democracy and Vanderbilt University Medical Center will host “Vaccine Hesitancy: The Politics of Public Health in Tennessee,” a virtual event, on Wednesday, Aug. 18, at noon CT. Read More

Helicobacter pylori, a stomach-dwelling bacterium, is a strong risk factor for gastric cancer, peptic ulcers and other debilitating gastrointestinal disorders. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about when COVID-19 vaccines will be fully approved. Read More

Join the School of Medicine Basic Sciences’ monthly Lab-to-Table series for a conversation with former Tour de France and Olympic athletes about science and cycling. The discussion will touch on the athletes’ personal experiences with training, coaching and medicine in cycling and how biomedical science has shaped their efforts. The virtual event will be Tuesday, Aug. 17, at 11 a.m. CT. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, discusses what we know about the delta variant of COVID-19.  Read More

Following decades of worldwide research standstills on cancer drug improvement, Steven Townsend and his team of researchers synthesize cancer therapeutics that bypass toxicity aimed at heart health. Est. reading time: 2.5 minutes. Read More

Lisa Monteggia leads discovery of the gene responsible for ketamine’s long-term effects with implications for antidepressant therapeutics. Est. reading time: 2.5 mins. Read More